Clinical Trial Update: DTA (Dopaminergic Therapy for Anhedonia) Study [Phase 4]

View source ↗

Summary

Phase 4 trial of Dopaminergic Therapy for Anhedonia has completed, with results posted on 2024-12-16.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia
• Major Depressive Disorder

Drugs mentioned

• Dopaminergic Therapy for Anhedonia (DTA)

Snippet

Sponsor: Emory University | Conditions: Depression, Anhedonia | Phase 4 | Status: COMPLETED | Results posted: 2024-12-16